Paragraph 18 Decentralised procedure where the United Kingdom is the reference member State
(1)
Where an application is submitted using the decentralised procedure the following fees are payable if the United Kingdom is the reference member State—
Fee for the decentralised procedure where the United Kingdom is the reference member State
| Type of application | Fee(£) |
|---|---|
| Standard application | 10,400 |
| Application for a new active substance | 29,510 |
| Complex application | 18,800 |
| Application for a pharmacologically equivalent product where the reference product is authorised in the United Kingdom | 9,000 |
| Application for a pharmacologically equivalent product where reference product is not authorised in the United Kingdom | 10,400 plus any translation costs |
| Application using identical data | 4,075 |
(2)
In each case the fee includes the provision of information to one member State in the application; there is a further fee of £500 for each additional member State included in the application.